JnJ seeks indication extension of Akeega from EMA for adults with metastatic hormone-sensitive prostate cancer, HRR gene alterations Written By Ruchika Sharma6 July 2025 12:30 PM ISTBelgium: Janssen-Cilag International NV, a Johnson & Johnson company, has announced the submission of an extension of indication application...
AstraZeneca Imfinzi approved in EU for muscle-invasive bladder cancer Written By Ruchika Sharma6 July 2025 11:00 AM ISTCambridge: AstraZeneca has received approval for Imfinzi (durvalumab) in the European Union (EU) for the treatment of adult patients...
Pfizer's Abrocitinib Phase III Data Accepted by CDSCO Expert Committee Parthika Patel6 July 2025 10:00 AM ISTNew Delhi: The Subject Expert Committee (SEC) under the Dermatology and Allergy division of the Central Drugs Standard Control Organisation (CDSCO)...
COVID-19 Vaccine and Heart Attack: Biocon Chief, Karnataka CM get into war of words Written By Ruchika Sharma5 July 2025 5:03 PM ISTBengaluru: A war of words has erupted between Biocon founder Kiran Mazumdar-Shaw and Karnataka Chief Minister Siddaramaiah on thursday over...
CDSCO Panel Asks Glenmark To Justify BE Waiver for FDC Inhalation Suspension With Scientific Evidence Written By Dr. Divya Colin5 July 2025 3:36 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has advised Glenmark...
Sun Pharma Gets SEC Nod to Begin Phase III Trial of Cough Drug Gefapixant Written By Dr. Divya Colin5 July 2025 3:21 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has recommended granting...
USFDA grants priority review for Winrevair label update based on ZENITH Trial: Merck Written By Ruchika Sharma5 July 2025 2:39 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA) has...
AstraZeneca, Summit in discussions over USD 15 billion cancer drug licensing deal: Report Written By Ruchika Sharma5 July 2025 12:47 PM ISTBengaluru: AstraZeneca is reportedly in discussions with Summit Therapeutics to license an experimental lung cancer drug in a deal that could be...
Bain Capital divests 2.4 percent stake in Emcure Pharma for Rs 563 crore Ruchika Sharma5 July 2025 11:57 AM ISTNew Delhi: US-based Private investment firm Bain Capital has pared down its stake in Emcure Pharmaceuticals, offloading a 2.4 percent...
Shilpa Pharma Lifesciences Unit-1 successfully completes GMP inspection from Brazilian regulatory authority Written By Ruchika Sharma4 July 2025 5:16 PM ISTKarnataka: Shilpa Medicare Limited's 100 percent subsidiary, Shilpa Pharma Lifesciences Limited, Unit-1 has successfully completed GMP inspection...
Lupin rolls out Nasal spray for rhinorrhea relief in US Written By Ruchika Sharma4 July 2025 3:23 PM ISTMumbai: Global pharma major Lupin Limited has launched Ipratropium Bromide Nasal Solution (Nasal Spray), 0.03% and 0.06%, in the United States. ...
Pfizer Told To Conduct Phase IV Trial of Abrocitinib in Indian Adolescents with Atopic Dermatitis Parthika Patel4 July 2025 3:00 PM ISTNew Delhi: In a recent regulatory development, the Subject Expert Committee (SEC) under the Dermatology and Allergy division of the Central Drugs...
